SOMA Breath Research

This meta-analysis from researchers at the University of Sussex and University of Oxford is the first to examine the effects of breathwork specifically (not as part of broader yoga or mindfulness programs) on stress, anxiety, and depression. Searching seven databases through February 2022, the authors identified 26 RCTs meeting inclusion criteria, with breathwork comprising at least 50% of each intervention.

For the primary outcome of self-reported stress (12 RCTs, n=785), breathwork produced a significant small-to-medium effect (Hedges' g = -0.35, p = 0.0009) with moderate heterogeneity (I-squared = 42%). Secondary outcomes showed similar benefits for anxiety (20 studies, g = -0.32, p < 0.0001) and depression (18 studies, g = -0.40, p < 0.0001). Most included studies used slow-paced breathing techniques (10 of 12 stress studies), and effects were significant across both in-person and remote delivery formats.

Subgroup analyses found no significant differences by population health status, breathing technique type, or delivery mode. Notably, no dose-response relationship emerged between intervention duration or session frequency and effect sizes. The authors caution that most studies carried moderate risk of bias and urge careful interpretation, warning against "miscalibration between hype and evidence" while acknowledging breathwork as a promising low-cost mental health intervention.

Research examining intermittent hypoxia effects on cellular aging markers.

This systematic review is the first to evaluate the therapeutic health effects of pranayama practiced alone (not combined with other yoga components) across controlled human trials. Searching PubMed, Web of Science, and Scopus through June 2017, the authors screened 669 articles and included 18 controlled clinical trials (13 randomized, 1 crossover) with sample sizes ranging from 16 to 160 participants and intervention durations from 4 days to 6 months.

The strongest evidence emerged for respiratory conditions: multiple trials in bronchial asthma patients showed significant improvements in pulse rate, systolic blood pressure, FVC, PEFR, and FEV1, along with reduced attack frequency, lower medication requirements, and improved quality of life. COPD patients showed improvements in symptom, activity, and impact scores. Cardiovascular benefits included significant reductions in systolic and diastolic blood pressure in hypertensive patients and anxiety reduction in cardiac patients.

In cancer patients, particularly breast cancer, pranayama significantly reduced cancer-related fatigue and improved emotional responses, sleep quality, and anxiety during chemotherapy. However, the overall quality of included studies was mixed: only 5 of 18 studies were rated good quality on the PEDro scale, while 6 were rated poor. The high heterogeneity across pranayama techniques, outcome measures, and populations prevented quantitative meta-analysis. Most studies (14 of 18) were conducted in India.

This comprehensive narrative review from S-VYASA University synthesized 68 experimental studies on yogic breathing (pranayama) techniques, drawing from 1,400 references identified across PubMed, PubMed Central, and IndMed databases. Unlike reviews that examine yoga as a whole, this paper focused exclusively on the effects of breath regulation practiced in isolation.

The review covers eight primary pranayama techniques: Kapalabhati (rapid abdominal breathing), Bhastrika (forceful bellows breathing), Nadishuddhi/Nadi Shodhan (alternate nostril breathing), Ujjayi (throat constriction breathing), Bhramari (humming breath), Suryanuloma Viloma (right nostril only), Chandranuloma Viloma (left nostril only), and Suryabhedana (right nostril-initiated breathing). Each technique produces distinct physiological responses -- for example, right nostril breathing activates sympathetic pathways and increases metabolic oxygen consumption, while left nostril breathing enhances parasympathetic activity.

Key findings include enhanced alpha brain waves during Kapalabhati, improved cognitive processing (increased P300 peak amplitudes) with alternate nostril breathing, maximized baroreflex sensitivity at 6 breaths per minute with slow equal-ratio breathing, significant improvements in pulmonary function (PEFR, FEV), reduced free radicals following practice, and reduced test anxiety (33% vs 67% in controls). Clinical applications span hypertension management, asthma stabilization, cardiac arrhythmia improvement, cancer symptom reduction, and smoking cessation support. The authors note that while the evidence base is promising, many studies lack methodological rigor and recommend larger trials with rigorous designs.